ClinicalTrials.Veeva

Menu

The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance

Purdue University logo

Purdue University

Status

Completed

Conditions

Oral Glucose Tolerance

Treatments

Other: aspartame
Other: water

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02999321
055-045

Details and patient eligibility

About

Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.

Full description

Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg aspartame. Participants will have an oral glucose tolerance test at the beginning and end of a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate. They will consume their intervention products daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12.

Enrollment

93 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI 18-25
  • Fasting blood sugar between 72 and 108 mg/dl via capillary finger-stick.

Exclusion criteria

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

93 participants in 3 patient groups

0% aspartame (water)
Experimental group
Description:
participants will not have any aspartame, this is a control.
Treatment:
Other: water
5 mg aspartame
Experimental group
Description:
participants will receive 5 mg aspartame in a beverage.
Treatment:
Other: aspartame
15mg aspartame
Experimental group
Description:
participants will receive 5 mg aspartame in a beverage, and 10mg in capsules.
Treatment:
Other: aspartame

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems